No abstract

SUMMARY Plasma and pituitary luteinizing hormone (LH) concentrations were measured by radioimmunoassay at different stages of the normal 4- and 5-day oestrous cycle of rats. Plasma levels were low except between the afternoon of pro-oestrus and the morning of oestrus when levels were high but variable. Pituitary LH content and concentration were less consistent but averaged values showed a steady rise from a low level after ovulation to a peak on the afternoon of pro-oestrus, and a rapid fall that evening when plasma levels rose rapidly. No significant differences were observed in plasma LH between 4- and 5-day cycles; in particular there was no reduction at metoestrus or dioestrus-1 or increase on the evening of dioestrus-2. Plasma oestradiol was already high on the morning of dioestrus-2 in some rats and in all rats by that evening. On the morning of pro-oestrus in the 5-day cycle, plasma oestradiol was still high but somewhat lower than at the corresponding stage in the 4-day cycle. Blocking ovulation by administration of sodium pentobarbitone at prooestrus in a 4-day cycle prevented the rise in plasma LH and the fall in pituitary content. Blocking generally failed in animals whose plasma LH had reached the level of 20 ng/ml or more at the time of injection. Plasma oestradiol levels on the morning of the expected day of oestrus were higher than normal in animals in which ovulation was blocked by pentobarbitone but were below pro-oestrous values. In the anovulatory state induced by exposure to constant light no major increase in plasma LH was detected after 24 days of illumination or after 3 months exposure. Animals rendered anovulatory by injection of testosterone propionate on the 4th day of postnatal life had low plasma LH levels as adults. All three groups had a low pituitary LH content. The animals exposed to long-term light and those treated with androgen generally had plasma oestradiol concentrations below the peak levels seen on the morning of pro-oestrus in the normal cycle.

Summary.-The prevalence of elevated serum levels of 5 potential tumour -associated antigens was determined in patients with lung cancer sampled at the time of initial presentation, using age-and sex-matched patients with benign lung disease as controls. Elevated levels (> upper 95th centile of controls) were found as follows:carcinoembryonic antigen (CEA), 17%; pregnancy-associated a-macroglobulin (PAM), 16%; casein 140o; human chorionic gonadotrophin (HCG) 6%; a-foetoprotein (AFP), 15%. The prevalence of elevated CEA levels (but not other markers) was higher in patients with evidence of extra-thoracic tumour spread (23%) mainly due to anaplastic tumours and adenocarcinomas.A degree of concordance of elevated marker levels occurred with CEA, HCG, casein and AFP, but there was a striking discordance of elevated CEA and PAM levels. Simultaneous assays of CEA and PAM will detect the majority of patients with elevations of any of the markers studied, and are likely to be the most useful biochemical markers in following the response of lung tumours to therapy.

A deficiency of neutral 17beta-hydroxysteroid oxidoreductase activity in testes has been diagnosed in a n infant with male pseudohermaphroditism. In vivo stimulation tests of testicular endocrine function with human chorionic gonadotrophin provided an accurate diagnosis in contrast to estimates of enzymic activity in vitro in testes and other tissues. The discrepancy in testes may be due to the absence of gonadotrophin stimulation in the latter studies. The in vitro studies show that there are at least two forms of 17beta-hydroxysteroid oxidoreductase under independent genetic control and that only one form is localized to the testes. The diagnosis before puberty has allowed early treatment by removal of the abnormal testes which should prevent the usual presenting clinical signs of marked masculinizatin and hirsutism at puberty.

One daily dose of either 5 mg or 10 mg cyproterone acetate (CA) was administered to 2 groups of 4 fertile men for 6 months. The medication was preceded by a 3 months placebo period and followed by a recovery phase of 5 to 8 months. During CA-treatment the sperm count/ml decreased and the percentage of abnormal spermatozoa increased slightly (0.001 < P < 0.05). Sperm penetration assessed by the Kremer test did not show any decrease during treatment. Serum levels of testosterone and FSH decreased, but those of LH remained unchanged during treatment. Two pregnancies occurred after 1¾ and 5½ months of CA-treatment. The serum-CA concentration in these 2 volonteers did not differ from that of the remainder. Three subjects who began the study were withdrawn because of depressive mood changes (2) and weakness combined with dizziness (1). Data from these subjects were not included. The results indicate that daily doses of 5 mg and 10 mg of cyproterone acetate are not effective as a male contraceptive.

Androstenedione, testosterone, progesterone and human chorionic gonadotrophin (HCG) in plasma and total oestrogens, luteinizing hormone (LH) and HCG in urine were measured in five women during conceptual cycles and in early pregnancy. There were increased levels in plasma and urine of all the hormones measured between 12 to 48 days after ovulation except progesterone. The concentration of this hormone in plasma decreased during this time. The possible sources of these hormones in early pregnancy are discussed. Steroids, 22,47. Steroids, 16, 415. Embryology, 31, No. 200, 65. Investigation, 45, 301. 607.

No abstract

SUMMARY Plasma luteinizing hormone (LH) concentrations were already lower on Day 2 of pregnancy than at the same time after the preceding ovulation in the non-pregnant rat, and fell progressively up to Day 16 of pregnancy. No evidence was obtained of any increase at the time when the ovulatory surge of LH would have occurred if the animal had not become pregnant. Pituitary LH concentration was lower in mated rats on the morning of Day 0 of pregnancy than in unmated controls on the morning of the day of oestrus. Subsequently it increased slowly to reach a level higher than at any stage of the oestrous cycle by Day 8 of pregnancy and remained high until at least Day 16 of pregnancy. Peripheral plasma oestradiol concentration increased late on Day 2 of pregnancy and was still raised on Day 4 but was never more than about one fourth of the peak concentration seen on the morning of prooestrus during the oestrous cycle. There were similar changes in plasma LH and oestradiol concentrations in the 48 h after a single injection of 2·5mg progesterone on the morning of the day of dioestrus, a procedure that delays ovulation by 1 or 2 days. Administration of a synthetic progestational compound (medroxyprogesterone acetate) to pregnant rats delayed blastocyst implantation and the delay was associated with a marked decrease in peripheral plasma LH to levels below those of normal pregnancy.